You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Exercise Disclosure
Stengone Carmine N. · SEC Form 4 · Filed Jul 8, 2026
Exercise
Calculated transaction value
$0
Stengone Carmine N. CEO And President
CTNM
Transaction date
Jul 8, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed same day
CTNM daily price context
Close on/before transaction
$15.65
Jul 8, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Class A Common Stock
- Quantity / price
- 2,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-047710
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$42.52K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM Current | Exercise | Jul 8, 2026 | $0 |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 8, 2026 | $2.52K |
| Contineum Therapeutics, Inc. CTNM | Sale | Jul 8, 2026 | $40K |